RSS Amplifier

Out Of Programme · Jun 30, 2026

🎙 Dr Alastair Darwood on Selling a Startup in FY1, Licensing Medical Device IP, and Why He Never Runs the Businesses He Creates

0
Sign in to vote or save

Out Of Programme · Out Of Programme

Dear Readers,

This week on Out of Programme, we’re joined by Dr Alastair Darwood — a medical doctor who sold a surgical robotics startup before finishing FY1, built a ventilator with Red Bull during COVID, raised £14M for an e-bike company, and licensed an analgesic mask to one of the world’s largest anaesthesia suppliers. His secret? He invents. He validates. He licenses. Then he moves on — and never runs the businesses he creates.

🎧 Watch the full episode on YouTube:

You can also listen on: 🎧 Spotify

Share

🔬 Selling a Startup in FY1 - As a medical student, Alastair invented a new approach to intraoperative arthroplasty, raised £170k, hired KPMG as M&A advisors, and sold the company to De Souter Medical before finishing his foundation year. The Solito robot is now in use on patients.

🫁 Red Bull and the COVID Ventilator - Alastair’s low-cost ventilator startup was partnered with Red Bull Advanced Technologies during the pandemic. Two months of intense work produced a device that was starting to work — before the government shut the programme down. The patent still sits unused.

🚴 Scarpa: £14M, Without Running the Business - Scarpa electrifies any bicycle without modifying the underlying bike. It has raised £14M, employs 22 people, and is in 70 shops across the UK. Alastair invented the technology. His co-founders run everything else. Deliberately.

😷 The Analgesic Mask - Tired of watching patients with minor procedures get sent home to fast for a full GA, Alastair designed patient-controlled inhalational analgesia. Licensed to Intersurgical, it is now in clinical trials at St Mary’s.

🤖 AI Has Turned Invention Into Lego Bricks - A project that would have taken a year now takes three weeks. Alastair built a power switching system, wrote the control code, and shipped a phone app — without hiring a single external consultant.

💡 Stop Optimising, Start Inventing - 95–98% of clinician innovation in the UK is optimisation. Alastair’s challenge: focus on problems you don’t know have an answer. Those are the only ones worth solving.

Alastair’s episode is proof that:

  • 🔬 You don’t need to build a company to be a successful inventor — licensing IP is a legitimate and often smarter playbook

  • 🤝 Knowing your own strengths and sticking to them is a superpower — Alastair has never pretended to be anything other than an inventor

  • 🤖 The barriers to hardware invention have fallen dramatically — if you have the imagination to define the problem, AI can now help you build the solution

  • 💡 The clinicians who will make the biggest impact are those willing to ask whether a problem should exist at all, not just how to solve it more efficiently

As Alastair says:

“Focus on a problem that you don’t know if it actually has an answer. Because those are the really exciting problems — and if you solve those problems, you’ve genuinely created something new.”

🧠 Interested in building in digital health?

Applications are open for the BiteLabs Digital Health, AI & Innovation Fellowship — cohorts in both the UK and the US.

BiteLabs is where clinicians build, launch and lead in digital health. 800+ fellows · 200+ advisors · £15M+ raised · Rated 4.9 on Google.

Apply via Out of Programme and you’ll receive: ✅ Extra points on your application 🎯 A 1:1 career coaching session with the BiteLabs team 🤝 A personal session with a BiteLabs founder

🔗 Apply at bitelabs.io 💬 Use referral code: OUTOFPROGRAMME in your application form

💡 Subscribe for more stories of career reinvention:

🗞️ Substack | ▶️ YouTube | 🎧 Spotify | 🍏 Apple Podcasts | 🔗 LinkedIn

If you know someone contemplating their next move — share this episode with them!

Until next time,

Dr Jing Ouyang

👉 Follow me on LinkedIn for a behind-the-scenes look and reflections on Out of Programme.

No posts

Read the original on outofprogramme.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.